Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna MRNA we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 23% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $1,183,210 and 7, calls, for a total amount of $341,156.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $22.5 to $40.0 for Moderna over the recent three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Moderna's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale activity within a strike price range from $22.5 to $40.0 in the last 30 days.
Moderna Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | NEUTRAL | 09/19/25 | $3.8 | $3.6 | $3.7 | $25.00 | $832.5K | 10.8K | 20 |
| MRNA | PUT | SWEEP | BULLISH | 09/19/25 | $3.65 | $3.55 | $3.55 | $25.00 | $127.0K | 10.8K | 2.6K |
| MRNA | CALL | TRADE | BEARISH | 06/20/25 | $6.55 | $6.25 | $6.33 | $22.50 | $63.3K | 1.7K | 350 |
| MRNA | CALL | TRADE | BULLISH | 06/20/25 | $6.35 | $6.3 | $6.35 | $22.50 | $62.8K | 1.7K | 450 |
| MRNA | PUT | SWEEP | BULLISH | 09/19/25 | $3.65 | $3.5 | $3.55 | $25.00 | $62.1K | 10.8K | 2.9K |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Having examined the options trading patterns of Moderna, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Moderna Standing Right Now?
- With a volume of 4,280,961, the price of MRNA is up 0.49% at $27.52.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 6 days.
What Analysts Are Saying About Moderna
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $32.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Morgan Stanley persists with their Equal-Weight rating on Moderna, maintaining a target price of $32.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
